Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Selecta Biosciences stock

Learn how to easily invest in Selecta Biosciences stock.

Selecta Biosciences Inc is a biotechnology business based in the US. Selecta Biosciences shares (SELB) are listed on the NASDAQ and all prices are listed in US Dollars. Selecta Biosciences employs 58 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Selecta Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SELB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Selecta Biosciences stock price (NASDAQ: SELB)

Use our graph to track the performance of SELB stocks over time.

Selecta Biosciences shares at a glance

Information last updated 2022-07-01.
Latest market close$1.33
52-week range$0.65 - $4.70
50-day moving average $0.95
200-day moving average $2.36
Wall St. target price$7.29
PE ratio 16.375
Dividend yield $0 (0%)
Earnings per share (TTM) $0.08

Buy Selecta Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Selecta Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Selecta Biosciences price performance over time

Historical closes compared with the close of $1.33 from 2022-07-01

1 week (2022-06-28) 2.31%
1 month (2022-06-03) 50.71%
3 months (2022-04-01) N/A
6 months (2022-01-01) N/A
1 year (2021-07-02) -68.78%
2 years (2020-07-02) -51.46%
3 years (2019-07-05) 1.74
5 years (2017-07-05) 19.58

Is Selecta Biosciences stock undervalued or overvalued?

Valuing Selecta Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Selecta Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Selecta Biosciences's P/E ratio

Selecta Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Selecta Biosciences shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Selecta Biosciences's EBITDA

Selecta Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million.

The EBITDA is a measure of a Selecta Biosciences's overall financial performance and is widely used to measure a its profitability.

Selecta Biosciences financials

Revenue TTM $108 million
Operating margin TTM 12.34%
Gross profit TTM $16.3 million
Return on assets TTM 5.17%
Return on equity TTM 153%
Profit margin 25.63%
Book value $0.45
Market capitalisation $198.9 million

TTM: trailing 12 months

Selecta Biosciences share dividends

We're not expecting Selecta Biosciences to pay a dividend over the next 12 months.

Selecta Biosciences share price volatility

Over the last 12 months, Selecta Biosciences's shares have ranged in value from as little as $0.647 up to $4.7. A popular way to gauge a stock's volatility is its "beta".

SELB.US volatility(beta: 1.34)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Selecta Biosciences's is 1.3385. This would suggest that Selecta Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Selecta Biosciences overview

Selecta Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising SEL-313, a product candidate in preclinical stage to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to evaluate the appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and products for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat primary biliary cholangitis and other autoimmune diseases. The company has license and collaboration agreements with Takeda Pharmaceuticals USA, Inc.

Frequently asked questions

What percentage of Selecta Biosciences is owned by insiders or institutions?
Currently 25.32% of Selecta Biosciences shares are held by insiders and 53.049% by institutions.
How many people work for Selecta Biosciences?
Latest data suggests 58 work at Selecta Biosciences.
When does the fiscal year end for Selecta Biosciences?
Selecta Biosciences's fiscal year ends in December.
Where is Selecta Biosciences based?
Selecta Biosciences's address is: 65 Grove Street, Watertown, MA, United States, 02472
What is Selecta Biosciences's ISIN number?
Selecta Biosciences's international securities identification number is: US8162121045
What is Selecta Biosciences's CUSIP number?
Selecta Biosciences's Committee on Uniform Securities Identification Procedures number is: 816212104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site